Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

被引:134
|
作者
Rodina, Anna
Vilenchik, Maria
Moulick, Kamalika
Aguirre, Julia
Kim, Joungnam
Chiang, Anne
Litz, Julie
Clement, Cristina C.
Kang, Yanlong
She, Yuhong
Wu, Nian
Felts, Sara
Wipf, Peter
Massague, Joan
Jiang, Xuejun
Brodsky, Jeffrey L.
Krystal, Geoffrey W.
Chiosis, Gabriela
机构
[1] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23249 USA
[4] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[5] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
[6] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[7] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA
关键词
D O I
10.1038/nchembio.2007.10
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.
引用
收藏
页码:498 / 507
页数:10
相关论文
共 50 条
  • [41] Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer
    Liu, Kang
    Kang, Min
    Li, Jixi
    Qin, Wen
    Wang, Rensheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) : 2657 - 2665
  • [42] Selective targeting of cancer cells using a hydrogen peroxide-activated Hsp90 inhibitor
    Oh, Yong Jin
    Park, Sun You
    Seo, Young Ho
    BIOORGANIC CHEMISTRY, 2021, 115
  • [43] Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90
    Burlison, Joseph A.
    Neckers, Len
    Smith, Andrew B.
    Maxwell, Anthony
    Blagg, Brian S. J.
    Journal of the American Chemical Society, 2006, 128 (48): : 15529 - 15536
  • [44] Assessment of Hsp90β-selective inhibitor safety and on-target effects
    Reynolds, Tyelor S.
    Mishra, Sanket J.
    Blagg, Brian S. J.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] Novobiocin: Redesigning a DNA gyrase inhibitor for selective inhibition of Hsp90
    Burlison, Joseph A.
    Neckers, Len
    Smith, Andrew B.
    Maxwell, Anthony
    Blagg, Brian S. J.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (48) : 15529 - 15536
  • [46] A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
    Zhang, Tao
    Hamza, Adel
    Cao, Xianhua
    Wang, Bing
    Yu, Shuwen
    Zhan, Chang-Guo
    Sun, Duxin
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (01) : 162 - 170
  • [47] FS23 binds to the N-terminal domain of human Hsp90:A novel small inhibitor for Hsp90
    李健
    石峰
    陈丹琦
    曹慧玲
    熊兵
    沈竞康
    何建华
    Nuclear Science and Techniques, 2015, 26 (06) : 110 - 116
  • [48] Combination of HSP90 and proteasome inhibitor is effective in pancreatic cancer
    Nagaraju, Ganji Purnachandra
    Rajitha, Balney
    Benton, Leah
    El-Rayes, Bassel F.
    CANCER RESEARCH, 2016, 76
  • [49] FS23 binds to the N-terminal domain of human Hsp90: A novel small inhibitor for Hsp90
    Li Jian
    Shi Feng
    Chen Dan-Qi
    Cao Hui-Ling
    Xiong Bing
    Shen Jing-Kang
    He Jian-Hua
    NUCLEAR SCIENCE AND TECHNIQUES, 2015, 26 (06)
  • [50] Hsp90 inhibitor as a sensitizer of cancer cells to different therapies
    Solarova, Zuzana
    Mojzis, Jan
    Solar, Peter
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 907 - 926